Why the study?
Cardiovascular clinical trials have historically under-represented females despite sex-based differences in epidemiology, treatment, and outcomes, leaving sex-specific arrhythmia care reliant largely on post hoc and secondary analyses.
Design
Review
Loading...
Post hoc sex analyses may flag outcome differences; leaves open need for dedicated prospective trials before changing practice.
This review emphasizes the need to recognize sex-based differences in arrhythmia presentation and management to optimize care for female patients.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: